Trade in falsified medicines is a global pandemic that is negatively affecting patients’ health and causing major losses to global economies. Over a million people die due to falsified medicines p.a, with losses costing billions of dollars and thousands of jobs.
the world's first IoT-based substandard and falsified (SF) medicines screening platform
Medi-Eval offers an adaptable, cloud-based chemical analysis system that provides non-invasive Drug Authentication and Tracking services in real time.
With "Solution as a Service" model our clients will have full access to the hardware, software, all system upgrades and maintenance for a fixed monthly service fee.
AI-based analytical system which is designed specifically to screen substandard and falsified pharmaceutical products.
Verifies label claims on the identity, quantity, content and manufacturer for substandard and falsified drug detection.
Comprehensive pharmaceutical finished products and raw material library.
Non-invasive chemical analysis
Artificial intelligence (AI)
(chemical fingerprint library of drug products)
Currently 175+ drug family (active ingredients of medicines) is covered.
Currently 370++ finished products from different drug families, manufacturers, batches, which are marketed mostly in Europe, are covered.
Currently 60++ vitamins/ supplements marketed in Europe and USA are covered.
New drugs and drug products are added periodically to expand the database.
New algorithms and smart chemical analysis models are developed periodically to meet the unique needs of countries and institutions.